Globus Medical (GMED) shares outstanding

Shares outstanding · fiscal 2025
137.06M

Globus Medical (GMED) had 137.06M diluted shares on average in fiscal 2025 (the year ended December 31, 2025). That is 0.6% lower than the 137.86M of fiscal 2024. Figures as of 18 Nov 2026, 12:41 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Shares outstanding, fiscal 2025
137.06M
Change on fiscal 2024
−0.6%
Growth, 5 years
+6.3% a year
Growth, 10 years
+3.6% a year
Highest on record
137.86Mfiscal 2024
Lowest on record
90.42Mfiscal 2011
Fiscal years on record
162010–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Globus Medical shares outstanding, in more detail

The market data feed counts 110.04M shares outstanding today.

Over the five fiscal years to 2025 the diluted share count grew at a compound 6.3% a year; over ten years the rate was 3.6% a year. Across the 16 fiscal years on record (2010–2025), the highest was 137.86M in fiscal 2024 and the lowest 90.42M in fiscal 2011.

History · 16 fiscal years

Shares outstanding by fiscal year

Globus Medical shares outstanding, year by year

Globus Medical (GMED) shares outstanding by fiscal year
Fiscal yearShares outstandingChangeYear ended
2025137.06M 0.6% down
2024137.86M 20.3% up
2023114.63M 11.7% up
2022102.64M 0.9% down
2021103.62M 2.6% up
2020100.97M 1.0% down
2019102.00M 0.7% up
2018101.32M 3.5% up
201797.89M 1.5% up
201696.43M 0.4% up
201596.07M 0.6% up
201495.46M 1.3% up
201394.19M 2.2% up
201292.21M 2.0% up
201190.42M 1.0% down
201091.35M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed.

How to read it

A falling count means buybacks are giving each remaining share a larger slice of the company; a rising one means owners are being diluted.

Shares outstanding at health care companies of similar size

Shares outstanding of Globus Medical and comparable companies
CompanyShares outstandingFiscal year
Spyre Therapeutics SYRE64.06M2025
Qiagen QGEN207.94M2025
Globus Medical GMED137.06M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on GMED

Globus Medical, figure by figure

Globus Medical (GMED) overview: price, valuation and scorecardAll health care companies by market value

Globus Medical shares outstanding: questions and answers

How many shares does Globus Medical have?

Globus Medical (GMED) had 137.06M diluted shares on average in fiscal 2025 (the year ended December 31, 2025). That is 0.6% lower than the 137.86M of fiscal 2024. The market data feed counts 110.04M shares outstanding today.

What is the growth rate of Globus Medical's diluted share count?

Over the five fiscal years to 2025 the diluted share count grew at a compound 6.3% a year; over ten years the rate was 3.6% a year.

What are the highest and lowest diluted share count figures on record for Globus Medical?

Across the 16 fiscal years on record (2010–2025), the highest was 137.86M in fiscal 2024 and the lowest 90.42M in fiscal 2011.

How is Globus Medical's diluted share count calculated?

The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed. For Globus Medical it is on record here for 16 fiscal years, 2010 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Globus Medical (GMED) shares outstanding”, data as of 18 November 2026. https://funkfolio.com/stock/GMED/shares-outstanding

Underlying data: the company's filings with the SEC and Yahoo Finance.